Welcome to our dedicated page for SS Innovations SEC filings (Ticker: SSII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating regulatory nuggets about the SSi Mantra surgical robotic system inside a 300-page filing is tedious. SS Innovations’ disclosures span R&D spending for new cardiac instruments, global regulatory milestones, and surgeon adoption metrics—layers of detail that can slow decision-making.
Stock Titan solves that problem. Our AI reads every SS Innovations quarterly earnings report 10-Q filing, flags changes in production costs, and translates medical-device jargon into plain language. Wondering about SS Innovations insider trading Form 4 transactions? Receive real-time alerts the moment executives trade shares, complete with context you can understand in seconds. From the latest SS Innovations annual report 10-K simplified to a sudden SS Innovations 8-K material events explained, every document arrives on your screen as soon as it hits EDGAR—already summarized.
Use cases investors rely on daily:
- Compare R&D outlays across robotic platforms with our AI-driven 10-K analysis
- Track SS Innovations executive stock transactions Form 4 before product-launch announcements
- Review surgeon-training commitments buried in the proxy—SS Innovations proxy statement executive compensation details included
Whether you need SS Innovations SEC filings explained simply or deep SS Innovations earnings report filing analysis, our platform delivers comprehensive coverage—10-Ks, 10-Qs, 8-Ks, S-1s, and more—paired with clear, AI-powered insights so you can act with confidence.
SS Innovations International (SSII) announced management participation in two investor conferences. The company will join the UBS Global Healthcare Conference in Palm Beach Gardens, FL on November 11, 2025, and the Stifel 2025 Healthcare Conference in New York, NY on November 12, 2025. The Stifel event includes a group presentation at 4:40 p.m. Eastern Time.
A live webcast and replay of the Stifel presentation will be available on the company’s website at https://ssinnovations.com/investor-overview/. The disclosure is provided under Item 7.01 (Regulation FD) and is deemed “furnished,” not “filed.”
SS Innovations International (SSII) furnished an updated October 2025 Company Presentation under Item 7.01 (Regulation FD). The presentation is attached as Exhibit 99.1 and is intended for communications with shareholders and the investment community.
The information is deemed “furnished” rather than “filed,” meaning it is not subject to Section 18 liability and is not incorporated by reference into other Securities Act or Exchange Act filings. The report also includes standard forward‑looking statements cautionary language.
Amar Naveen Kumar is reported as an officer (CFO) and director of SS Innovations International, Inc. (SSII). The Form 3 shows no beneficial ownership of the issuer's common stock and no derivative holdings are disclosed. The filing provides the reporting person's address in Fort Lauderdale, FL and includes the required signature attestation.
Insider transactions reported for SS Innovations International, Inc. (SSII) by Sudhir Srivastava, Chairman and CEO. The filing shows two non-derivative transactions in early September 2025: on 09/03/2025 Mr. Srivastava was reported as acquiring 2,500 shares, and on 09/05/2025 he was reported as disposing of 105,000 shares. After these transactions, the total shares beneficially owned attributable to Mr. Srivastava through Sushruta Pvt. Ltd. is reported as 112,583,014 shares. The form states the holdings are indirect because the reporting person has a controlling interest in Sushruta Pvt. Ltd.
Sudhir Srivastava, identified as a Director, 10% owner and the company's Chairman and CEO, reported a series of non-derivative transactions in the common stock of SS Innovations International, Inc. (SSII) executed through an entity he controls, Sushruta Pvt. Ltd. The Form 4 shows multiple acquisitions and dispositions between 05/12/2025 and 08/11/2025, including total reported acquisitions of 60,000 shares and total reported dispositions of 111,000 shares. After the last reported transaction the beneficial ownership held indirectly by Sushruta Pvt. Ltd. is shown as 112,685,514 common shares. Table II (derivative securities) contains no entries. The filing includes an explanatory note that the reporting person has a controlling interest in Sushruta Pvt. Ltd., which holds the securities of record.
FAQ
What is the current stock price of SS Innovations (SSII)?
What is the market cap of SS Innovations (SSII)?
